Applications focused on LC/SQ - page 12

Comprehensive Aggregate Profiling of Liraglutide and Semaglutide Using an Agilent 1290 Infinity II Bio 2D-LC and Agilent InfinityLab LC/MSD XT

Applications
| 2024 | Agilent Technologies
2D-LC, LC/MS, LC/SQ
Instrumentation
2D-LC, LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Leveraging Mobile Phase pH to Optimize Separations for Improved Prep Performance Using Columns Packed With Waters™ Hybrid Particles

Applications
| 2024 | Waters
Consumables, LC columns, LC/MS, LC/SQ
Instrumentation
Consumables, LC columns, LC/MS, LC/SQ
Manufacturer
Waters
Industries

Driving the Field of Oligonucleotide Therapeutics

Guides
| 2024 | Agilent Technologies
RAMAN Spectroscopy, FTIR Spectroscopy, HPLC, LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, UV–VIS spectrophotometry, LC/QQQ, ICP/MS, GC, HeadSpace, GC/MSD, Consumables, LC columns, LC/SQ, Software, GC/SQ, PrepLC
Instrumentation
RAMAN Spectroscopy, FTIR Spectroscopy, HPLC, LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, UV–VIS spectrophotometry, LC/QQQ, ICP/MS, GC, HeadSpace, GC/MSD, Consumables, LC columns, LC/SQ, Software, GC/SQ, PrepLC
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Rapid Confirmation of GLP-1 Analog (Liraglutide) Using Agilent InfinityLab LC/MSD iQ

Brochures and specifications
| 2024 | Agilent Technologies
LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

An Alternative Approach for NDMA Quantification in Metformin Final Product by LC/MS 2050 Single Quadrupole

Posters
| 2024 | Shimadzu (ASMS)
LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Determination of Paraquat in Drinking Water by LCMS-2050

Posters
| 2024 | Shimadzu (ASMS)
LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Shimadzu
Industries
Environmental

Oligonucleotide Characterization for Quality Control on the Shimadzu LCMS-2050

Posters
| 2024 | Shimadzu (ASMS)
LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Method Development of Proteolysis Targeting Chimera (PROTAC) Compound ARV-825 Forced Degradation Sample Using the Systematic Screening Protocol

Applications
| 2024 | Waters
LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma

Development of Separation Methods for GLP-1 Synthetic Peptides Utilizing a Systematic Protocol and MaxPeak™ High Performance Surface Technology

Applications
| 2024 | Waters
LC/MS, LC/SQ, HPLC
Instrumentation
LC/MS, LC/SQ, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Method Development for the Chromatographic Separation of Synthetic Cyclic Peptides and Impurities Utilizing a Systematic Protocol and MaxPeak High Performance Surface Technology

Applications
| 2024 | Waters
HPLC, LC/MS, LC/SQ
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike